MetLife Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.9M Sell
26,470
-1,227
-4% -$644K 0.08% 226
2025
Q1
$17.6M Sell
27,697
-543
-2% -$344K 0.09% 181
2024
Q4
$20.1M Buy
28,240
+273
+1% +$194K 0.11% 139
2024
Q3
$29.4M Sell
27,967
-708
-2% -$744K 0.17% 96
2024
Q2
$30.1M Buy
28,675
+3,708
+15% +$3.9M 0.18% 90
2024
Q1
$24M Sell
24,967
-1,239
-5% -$1.19M 0.16% 104
2023
Q4
$23M Sell
26,206
-429
-2% -$377K 0.17% 103
2023
Q3
$21.9M Sell
26,635
-961
-3% -$791K 0.17% 99
2023
Q2
$19.8M Sell
27,596
-675
-2% -$485K 0.14% 113
2023
Q1
$23.2M Sell
28,271
-230
-0.8% -$189K 0.17% 101
2022
Q4
$20.6M Sell
28,501
-509
-2% -$367K 0.16% 110
2022
Q3
$20M Sell
29,010
-623
-2% -$429K 0.17% 99
2022
Q2
$17.5M Buy
29,633
+196
+0.7% +$116K 0.14% 126
2022
Q1
$20.6M Buy
29,437
+6,078
+26% +$4.24M 0.13% 119
2021
Q4
$14.8M Sell
23,359
-381
-2% -$241K 0.12% 131
2021
Q3
$14.4M Sell
23,740
-533
-2% -$323K 0.13% 132
2021
Q2
$13.6M Sell
24,273
-817
-3% -$456K 0.12% 140
2021
Q1
$11.9M Sell
25,090
-376
-1% -$178K 0.11% 157
2020
Q4
$12.3M Sell
25,466
-1,041
-4% -$503K 0.12% 148
2020
Q3
$14.8M Buy
26,507
+126
+0.5% +$70.5K 0.16% 110
2020
Q2
$16.5M Buy
26,381
+5,790
+28% +$3.61M 0.19% 98
2020
Q1
$10.1M Sell
20,591
-630
-3% -$308K 0.14% 141
2019
Q4
$7.97M Sell
21,221
-525
-2% -$197K 0.08% 214
2019
Q3
$6.03M Buy
21,746
+69
+0.3% +$19.1K 0.07% 274
2019
Q2
$6.78M Sell
21,677
-606
-3% -$190K 0.07% 245
2019
Q1
$9.15M Buy
22,283
+83
+0.4% +$34.1K 0.1% 187
2018
Q4
$8.29M Sell
22,200
-344
-2% -$128K 0.1% 184
2018
Q3
$9.11M Sell
22,544
-224
-1% -$90.5K 0.09% 193
2018
Q2
$7.86M Sell
22,768
-472
-2% -$163K 0.09% 189
2018
Q1
$8M Sell
23,240
-596
-3% -$205K 0.09% 196
2017
Q4
$8.96M Buy
+23,836
New +$8.96M 0.1% 181